“Gas station heroin” is a street nickname for tianeptine, a pharmaceutical compound sold in some U.S. convenience stores and gas stations as a dietary supplement. It is not heroin, but the name stuck because tianeptine activates the same brain receptors that heroin and other opioids do, producing similar effects and carrying real risks of dependence, overdose, and death. The FDA has not approved tianeptine for any medical use in the United States and has issued warnings linking these products to serious harm.
What Tianeptine Actually Is
Tianeptine was originally developed as an antidepressant and is legally prescribed in some countries outside the U.S. for that purpose. For years, scientists believed it worked differently from opioids. More recent research has shown that tianeptine is actually a high-efficacy agonist at the mu-opioid receptor, the same receptor targeted by morphine, fentanyl, and heroin. In lab studies, tianeptine activated this receptor with even greater maximum effect than a classic opioid reference compound, and it was completely inactive in mice genetically engineered to lack the receptor. In other words, tianeptine’s mood-altering and pain-relieving effects depend entirely on opioid pathways in the brain.
In the U.S., tianeptine has been illegally marketed as a dietary supplement and sold under brand names like ZaZa, Tianna, Tiara, Neptune’s Fix, and Neptune’s Elixir. These products are typically found behind the counter at gas stations, smoke shops, and convenience stores, packaged in small bottles or capsules with vague labels that claim benefits for mood, focus, or anxiety.
Why It’s Considered Dangerous
The core problem is dosing. In countries where tianeptine is prescribed, doctors use carefully controlled daily amounts. Reports to the FDA describe U.S. consumers taking daily doses between 1.3 and 250 times the amount typically recommended in those countries. Because these products are sold as supplements with no standardized dosing, buyers have little way of knowing how much they’re actually taking.
The FDA has linked tianeptine products to agitation, drowsiness, confusion, sweating, rapid heartbeat, high blood pressure, nausea, vomiting, slowed or stopped breathing, coma, and death. Poison control data from the CDC paints a similar picture: among tianeptine-only exposures reported to the National Poison Data System, about 48% involved neurological symptoms, 33% involved cardiovascular effects like rapid heart rate and high blood pressure, and 5% involved respiratory depression, which is the same breathing slowdown that makes opioid overdoses lethal.
Some of these products are also used alongside other drugs, including antidepressants and anti-anxiety medications, which can compound the risks in unpredictable ways.
How Dependence Develops
Because tianeptine hits the same opioid receptor as drugs like heroin and prescription painkillers, it creates the same cycle of tolerance, dependence, and withdrawal. People who use it regularly find they need higher doses to feel the same effect, and stopping abruptly triggers withdrawal symptoms that mirror opioid withdrawal: muscle pain, chills, anxiety, nausea, vomiting, tremors, insomnia, diarrhea, intense cravings, agitation, and rapid heartbeat. Withdrawal generally improves within 24 to 48 hours, but the experience can be severe enough to send people to emergency rooms.
Many users don’t expect this. They bought a product from a gas station shelf, not from a drug dealer, and the packaging suggests it’s a harmless supplement. By the time they realize they’re physically dependent, they may be consuming large quantities daily and spending significant money to avoid withdrawal.
Where It’s Legal and Where It’s Banned
At the federal level, tianeptine is not a scheduled controlled substance, which is the main reason it has been able to slip into retail settings. However, a growing number of states have moved to ban or restrict it. As of early 2024, states that have classified tianeptine as a controlled substance include Alabama, Indiana, Kentucky, Michigan, Minnesota, Ohio, Virginia, Georgia, and Florida (all as Schedule I, the most restrictive category), along with Arkansas, Oklahoma, and Tennessee (Schedule II) and Mississippi (Schedule III).
In states without bans, tianeptine products can still be found on shelves, though the FDA continues to warn consumers against using them and has taken action against specific manufacturers and products. The patchwork of state laws means availability varies dramatically depending on where you live.
Treatment for Tianeptine Dependence
Because tianeptine acts on opioid receptors, the same treatments used for opioid addiction have shown promise. Buprenorphine-naloxone (the combination used in standard opioid addiction treatment) has been successfully used to limit withdrawal symptoms and support abstinence in people dependent on tianeptine. Methadone has also been used in case reports. The treatment experience looks similar to what someone addicted to prescription opioids or heroin might go through: stabilization with medication, management of withdrawal, and ongoing support to prevent relapse.
The key challenge is recognition. Many emergency departments and addiction treatment providers are still unfamiliar with tianeptine, and standard drug tests don’t detect it. Someone showing up with opioid-like withdrawal symptoms but a negative drug screen may be using tianeptine without the treatment team immediately realizing it.